European Medicines Agency
-
{
- All
- News
- Videos
-
EU Secures Emergency Deliveries Of Potential Treatment Against Hantavirus
The European Union is launching emergency procurement procedures to secure additional doses in case further hantavirus cases are confirmed in the coming weeks.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Two Vaccine Doses "Vital" Against Delta Variant Of Covid: European Regulator
The European Union's medicines watchdog said Wednesday two jabs by approved vaccine makers were "vital" to provide maximum protection against the highly-infectious coronavirus Delta variant, urging countries to speed up their inoculation drives.
-
Data Gaps Prevented European Efforts To Assess Sputnik V Vaccine: Report
The developers of Russia's Sputnik V coronavirus vaccine have repeatedly failed to provide data needed for the drug approval process, according to five people in the know of European efforts to assess the drug, reported news agency Reuters.
-
Confident Europe Medicine Body Will Approve Covishield In A Month: Serum's Adar Poonawalla
Vaccine major Serum Institute of India (SII) is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's Chief Executive Officer Adar Poonawalla said today.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
-
Covid Vaccine Access Needed "Throughout World": European Medicines Agency
The head of the European Medicines Agency told AFP on Friday that all countries must have access to coronavirus vaccines, as G7 leaders were expected to pledge to donate one billion doses to poor nations.
-
Pfizer Vaccine For 12-15 Year Olds Approved By European Medicines Agency
The European Medicines Agency on Friday approved the Pfizer/BioNTech coronavirus jab for 12- to 15-year-olds, the first vaccine to get the green light for children in the EU.
-
AstraZeneca Vaccine Benefits Increase With Age: EU Drug Watchdog
The EU's drug watchdog said Friday that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
-
Johnson & Johnson Vaccine's Benefits Outweigh Rare Blood Clots Risk: EU Agency
Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
-
EU Secures Emergency Deliveries Of Potential Treatment Against Hantavirus
The European Union is launching emergency procurement procedures to secure additional doses in case further hantavirus cases are confirmed in the coming weeks.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Two Vaccine Doses "Vital" Against Delta Variant Of Covid: European Regulator
The European Union's medicines watchdog said Wednesday two jabs by approved vaccine makers were "vital" to provide maximum protection against the highly-infectious coronavirus Delta variant, urging countries to speed up their inoculation drives.
-
Data Gaps Prevented European Efforts To Assess Sputnik V Vaccine: Report
The developers of Russia's Sputnik V coronavirus vaccine have repeatedly failed to provide data needed for the drug approval process, according to five people in the know of European efforts to assess the drug, reported news agency Reuters.
-
Confident Europe Medicine Body Will Approve Covishield In A Month: Serum's Adar Poonawalla
Vaccine major Serum Institute of India (SII) is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's Chief Executive Officer Adar Poonawalla said today.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
-
Covid Vaccine Access Needed "Throughout World": European Medicines Agency
The head of the European Medicines Agency told AFP on Friday that all countries must have access to coronavirus vaccines, as G7 leaders were expected to pledge to donate one billion doses to poor nations.
-
Pfizer Vaccine For 12-15 Year Olds Approved By European Medicines Agency
The European Medicines Agency on Friday approved the Pfizer/BioNTech coronavirus jab for 12- to 15-year-olds, the first vaccine to get the green light for children in the EU.
-
AstraZeneca Vaccine Benefits Increase With Age: EU Drug Watchdog
The EU's drug watchdog said Friday that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
-
Johnson & Johnson Vaccine's Benefits Outweigh Rare Blood Clots Risk: EU Agency
Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
